Status:
COMPLETED
Blood Culture Improvement Guidelines and Diagnostic Stewardship for Antibiotic Reduction in Critically Ill Children
Lead Sponsor:
Johns Hopkins University
Conditions:
Sepsis
Bacteremia
Eligibility:
All Genders
Brief Summary
This study will test the hypothesis that reliable implementation of an evidence-based clinical practice guideline for evaluation of patients with signs and symptoms of sepsis will decrease antibiotic ...
Detailed Description
The Bright STAR Collaborative (BSC), or Blood Culture Improvement Guidelines and Diagnostic Stewardship for Antibiotic Reduction in Critically Ill Children Collaborative, is a multicenter quality impr...
Eligibility Criteria
Inclusion
- Institutions that plan to develop and implement a quality improvement program to reduce blood culture use in their ICUs
Exclusion
- No exclusion criteria
Key Trial Info
Start Date :
April 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 28 2021
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT03441126
Start Date
April 1 2018
End Date
December 28 2021
Last Update
March 11 2022
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Louis Children's Hospital, Washington University
St Louis, Missouri, United States, 63110
2
Rainbow Babies & Children's Hospital
Cleveland, Ohio, United States, 44106
3
OHSU Doernbecher Children's Hospital
Portland, Oregon, United States, 97239
4
Dell Children's Medical Center of Central Texas
Austin, Texas, United States, 78723